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Polycystic kidney disease results from loss of function
of either of two novel proteins, polycystin-1 or
polycystin-2. Recent studies show that intracellular
calcium signaling is important in kidney development,
and define defects in this signaling pathway as the
basis of cyst formation in polycystic kidney disease.
Addresses: Departments of *Internal Medicine, *Genetics,
†Pharmacology and †Cellular & Molecular Physiology, Yale University
School of Medicine, New Haven, Connecticut, USA.
E-mail: stefan.somlo@yale.edu; barbara.ehrlich@yale.edu
Current Biology 2001, 11:R356–R360
0960-9822/01/$ – see front matter 
© 2001 Elsevier Science Ltd. All rights reserved.
The inherited human disorder known as autosomal
dominant polycystic kidney disease, ADPKD for short,
affects more than 1 in 1000 live births and is the most
common monogenic cause of kidney failure in man [1]. In
the mid 1990s, two genes, PKD1 and PKD2, were identi-
fied as the sites of mutations responsible for ADPKD, with
virtually indistinguishable pathologies. The molecular char-
acterization of these genes was achieved by positional
cloning [2,3], facilitated by early phases of the human
genome project. The products of these two genes, dubbed
polycystin-1 and polycystin-2, were both novel proteins,
though they did show some sequence similarity to each
other [3]. The dominance of PKD1 and PKD2 mutations
was subsequently found to be caused by somatic mutation
of the wild-type allele [4,5]. This is reminiscent of the way
tumor suppressor mutations cause cancer predisposition
syndromes; in both cases, a ‘second hit’ mutation leads to
homozygous loss of function.
The near identity of the diseases caused by PDK1 or PDK2
mutation, either in humans or mice mutant for homologs of
these genes [6,7], together with the discovery that poly-
csytin-1 and polycsytin-2 can physically interact [8,9], led to
the suggestion that two proteins exhibit functional coopera-
tivity. From their sequences, polycystin-1 and polycystin-2
were predicted to be components of a receptor/channel
complex. Indirect evidence to support this hypothesis came
from studies of structurally related proteins in other organ-
isms [10–12]. Now, Gonzalez-Perrett et al. [13] have reported
the first direct evidence that polycystin-2 is indeed a cation
channel, while Hanaoka et al. [14] have found that co-
expression and co-assembly of the two polycystins induces a
novel cell-surface cation channel activity. The elusive in vivo
functions of the ADPKD proteins are slowly coming to light,
and with this should come improved understanding of both
human disease and fundamental cellular processes.
Polycystin-1 is an integral membrane glycoprotein of
about 4300 amino acids, predicted to have an extracellular
domain of about 3000 amino acids with a multitude of
putative interaction domains, eleven membrane-spanning
regions and a small cytoplasmic tail (Figure 1) [15].
Polycystin-2 is predicted to have six membrane-span-
ning regions, and is the prototypical member of a sub-
family of the ‘TRP’ superfamily of Ca2+ channel proteins
(Figure 1). Polycystin-2 also exhibits sequence similarity
with the last six membrane-spanning regions of poly-
cystin-1 [3], indicating that polycystin-1 might also partici-
pate in channel function. The sequencing of diverse
genomes from prokaryotes to man has shown that proteins
related to polycystin-1 and polycystin-2 are highly con-
served throughout metazoan evolution, but are absent
from unicellular organisms.
A protein related to polycystin-1 has been shown to play a
part in fertilization: this is the receptor protein REJ, a com-
ponent of the sea urchin sperm membrane which mediates
the ‘acrosome reaction’ — a calcium-regulated exocytic
membrane fusion process that is an essential part of fertil-
ization [10]. A variant of REJ, REJ3, has been shown to be
proteolytically cleaved at a so-called ‘GPS’ domain into
roughly equal-sized polypeptides [16]. Antibodies against
the carboxy-terminal half of REJ3 are sufficient to induce
calcium influx and the acrosome reaction, although it is
uncertain whether REJ3 itself forms part of the channel
[16]. The GPS domain is conserved in polycsytin-1, raising
the possibility that human polycystin-1 is also cleaved
in vivo [15]. Sea urchin sperm also contains a homolog of
polycystin-2 [17].
A homolog of PKD1 has also been identified in the
nematode worm Caenorhabditis elegans — lov-1, a gene
essential for male mating function [11]. Unlike REJ3,
LOV-1 has an unrelated extracellular domain but mem-
brane-spanning segments similar to those of the poly-
cystins. C. elegans also has a homolog of PKD2, which is
expressed in the same subset of ciliated sensory neurons as
lov-1, supporting the view that polycystin-related proteins
have acted in common cellular pathways throughout evo-
lution [11]. Most recently, mutations in a human protein
related to polycystin-2 have been found to cause mucolipi-
dosis, type IV disease [18]. This storage disorder results
from defects in membrane sorting and the late stages of
endocytosis. Taken together, the phenotypes in these
pathways involving polycystin-related proteins suggest a
general role in chemosensory or mechanosensory signal
transduction affecting intracellular transport of proteins
and lipids.
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Following the discovery of PKD2 [3], several homologous
genes have been identified from expressed sequence tag
(EST) and genome databases of a variety of organisms.
One of the human proteins, polycystin-like (PCL) was
found, when its gene was expressed in Xenopus oocytes, to
behave as a calcium-modulated, calcium-permeable, non-
selective cation channel [12]. This was the first demonstra-
tion of channel activity for a member of the polycystin
family. Formal demonstration that polycystin-2 is a channel,
however, remained elusive, at least in part because poly-
cystin-2 does not translocate to the plasma membrane in
most cell-based systems [14,19]. This limitation was over-
come in the recent work of Gonzalez-Perrett et al. [13],
who made single channel recordings in reconstituted
planar lipid bilayers. They obtained very similar results
using polycystin-2 from a variety of sources, including
apical membrane vesicles from human placental syncy-
tiotrophoblasts, epitope-tagged affinity-purified protein and
in vitro translated protein.
Gonzalez-Perrett et al. [13] found that polycystin-2 behaves
as a large conductance, non-selective cation channel with
similar relative ion selectivities for Ca2+, Na+ and K+. This
differs from PCL, which exhibits four-fold higher selectiv-
ity for Ca2+ than for monovalent cations [12]. The mea-
sured single channel conductance for polycystin-2  was
approximately 140 pS [13], similar to that observed for
PCL [12], although the polycystin-2 channel displayed a
range of subconductance states not seen in the latter
homolog. The polycystin-2 conductance was found to be
inhibited by Ca2+, La3+, Gd3+, lower pH and amiloride
[13], whereas the PCL conductance is activated by Ca2+
[12]. It is interesting to note that Gonzalez-Perrett et al.
[13] detected polycystin-2 channel activity on the surface
of Sf9 cells expressing PKD2 from a baculovirus vector.
This is the first time that cell-surface localization of poly-
cystin-2 has been achieved by expression of PKD2 alone in
a cell-based system [19], and may be due to the massive
amounts of protein produced in the system overwhelming
the endogenous retention machinery.
Hanaoka et al. [14] have found a way of expressing poly-
cystin-2 on the surface of mammalian cells in culture that
may be somewhat more physiological. By co-immunopre-
cipitating epitope-tagged versions of polycystin-1 and
polycystin-2 from doubly transfected cells, they confirmed
that in vivo physical association of the two proteins
requires both proteins to have intact carboxyl termini. It
had previously been shown that full-length polycystin-2
is confined to pre-middle Golgi membranes, and does not
appear on the plasma membrane [19]. Hanaoka et al. [14]
found that full-length polycystin-2 can achieve plasma
membrane localization in the presence of heterologously
expressed polycystin-1 [14]. Similar findings had previ-
ously been reported for transfected cells expressing
polycystin-2 and TRPC1, a store-operated Ca2+ channel,
although no functional cell-surface channel complexes
were demonstrated in that study [20].
In the cell-based system used by Hanaoka et al. [14], the
association between polycystin-1 and polycystin-2, and the
consequent chaperoning of polycystin-2 to the cell surface,
Figure 1
Schematic representation of the domain
structure, topology and association of
polycystin-1 and polycystin-2 (not to scale).
Polycystin-1 is predicted to have an ~3,000
amino acid extracellular region with a complex
domain structure, followed by 11 membrane
spans and a cytoplasmic tail. The predicted
domain structure is based on reference [15].
Polcystin-2 has ~1,000 amino acids with six
membrane spans and intracellular amino and
carboxyl termini. The region of similarity
between the proteins resides in the like-
shaded membrane spans. Polycystin-1 and
polycystin-2 require intact carboxyl termini and
the coiled-coil domain to interact with each
other [8,9,14]. This association is essential for
their normal function. The GPS domain is a

















produces a novel non-selective cation channel that is Ca2+
permeable and outwardly rectifying [14]. This channel
activity is not observed if the interaction between the
polycystins is prevented by removing the carboxyl termi-
nus of either protein [14]. Whole-cell patch-clamp mea-
surements showed that the polycystin channel is six-fold
more permeable to Ca2+ than to monovalent cations. This
relative ion selectivity is similar to that for PCL [12], but
differs from that reported for polycystin-2 in the bilayer
studies [13]. The polycystin-1/2 channel did, however,
show similar inhibition by Ca2+, La3+ and niflumic acid to
that reported for the reconstituted polycystin-2 channel
[13]. The polycystin-1/2 and PCL channels have relative
Ca2+:monovalent cation permeabilties typical of the TRP
channel family [14,21]; the single channel conductances
reported for polycystin-2 alone are at least two-fold higher
than those for any TRP channel reported to date [13,21].
Hanaoka et al. [14] argue that, given the similarity of the
observed channel properties of the polycystin-1/2 channel
to PCL, it is most likely that polycystin-2 functions as the
cation channel in the co-assembled complex. The data do
not, however, exclude the possibility that polycystin-1
forms the channel and that the absence of activity when
either polycystin is truncated is due to a failure to deliver
polycystin-1 to the cell surface. The data also do not
exclude the possibility that other, as yet undefined, com-
ponents at the cell surface contribute to the channel [22].
Although it is tempting to speculate that the co-assembled
complex in transfected cells is representative of the poly-
cystin-1/2 channel that functions in vivo, the final arbiter
of the primary site of action of polycystin-2 will be studies
based in native kidney, where both polycystins are known
to be produced and functional.
Overall, these recent discoveries support the notion that
loss of function of either polycystin-1 or polycystin-2
interferes with the proper subcellular localization, assem-
bly, activity and regulation of a novel epithelial channel
complex. Loss of the polycystin complex does not,
however, manifest as a defect in electrolyte handling by
the kidney; rather, it results in dysregulation of Ca2+ sig-
naling that controls renal epithelial cell growth and pro-
motes normal tubular morphogenesis and function [14].
Experimentally, polycystin-1 stably over-expressed in
MDCK cells exerts anti-proliferative and anti-apoptotic
effects, while inducing spontaneous tubule formation in an
ex vivo model of renal tubular morphogenesis [23]. Fur-
thermore, studies of the human disease and mouse mutant
models have shown that polycystin-1 and polycystin-2 are
critical for both the establishment and maintenance of the
polarized epithelial phenotype — loss of either protein at
the level of a single cell results in loss of this specialized
phenotype [5–7].
Extensive studies on the origins of epithelial cell polarity
have shown that it requires both cell–substratum and
cell–cell interactions, very much in keeping with the func-
tion predicted for polycystin-1 based on its primary struc-
ture. Recent demonstrations that polycystin-1 is localized
primarily to the lateral membrane of polarized cells [24,25],
and that the extracellular domain is capable of strong
homophilic interactions [26], point more to a role in
cell–cell interactions. The new studies [13,14] define one
of the earliest intracellular steps of the polycystin signaling
pathway as being mediated by Ca2+. While neither poly-
cystin-1 nor polycystin-2 is likely to participate in the acro-
some reaction directly, our understanding of the ligand and
channel events underlying sperm capacitation is currently
the best available in vivo molecular insight we have into
the action of proteins structurally related to polycystins. 
With the available data [27], it is possible to pose a specu-
lative model for how polycystins may function in polarized
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Figure 2
Polycystin-1 and polycystin-2 function in
intracellular calcium signaling. The diagram
illustrates speculative pathways of polycystin
signaling based on the understanding of the
acrosome reaction [27] in which polycystin-1-
related proteins play a role [10,16,17].
Polycystin-1 is a cell surface receptor with
possible channel activity, while polycystin-2 is
a calcium channel located either in the
endoplasmic reticulum (a) [19] or plasma
membrane (b) [14]. Localized increases in
intracellular calcium may effect secretory
vesicle transport unique to tubular epithelia, or
regulate gene transcription programs required
for the differentiated phenotype of these cells.
See text for details. PKD1, polycystin-1;
PKD2, polycystin-2; EM, unknown effector
molecules; PLC, phospholipase C; SOC,
store operated channel; IP3, inositol 1,4,5-
trisphosphate; IP3R, IP3 receptor.





















epithelia (Figure 2). In the model, polycystin-1 is targeted
to the basolateral membrane where it complexes with
polycystin-2, which is either in the plasma membrane or in
the endoplasmic reticulum (ER) in close apposition to the
plasma membrane (Figure 2). Signals from external stimuli
— such homophilic interactions or as yet unknown ligands
— are transduced by polycystin-1 in association with effec-
tor molecules, for example, polycystin-2, the ‘regulator of
G protein signalling’ RGS7 [28] or other, so far unknown
participants. This activation results in increased local
[Ca2+]i (Figure 2). If polycystin-2 is on the cell surface, this
increase in [Ca2+]i results primarily from movement of
extracellular Ca2+ into the cell, but may be augmented by
local release of Ca2+ from intracellular stores [27]. If poly-
cystin-2 is in the ER, then cation translocation across the
plasma membrane, perhaps through polycystin-1 and asso-
ciated proteins, could trigger the augmentation by Ca2+
release from cytoplasmic stores through opening of the
polycystin-2 channel. Whether the receptor for the Ca2+-
mobilizing messenger inositol 1,4,5-trisphosphate (IP3) is
involved in intracellular Ca2+ release in this pathway is
uncertain. In either configuration, store-operated Ca2+
channels [20] may be activated in response to intracellular
store depletion.
Localized increases in [Ca2+]i can modulate a variety of
subcellular processes. Among these processes are targeted
fusion of specialized cytosolic vesicles with the plasma
membrane, or activation of kinase cascades leading to cell-
type specific gene expression. Either or both of these
processes could mediate the function of the polycystin
pathway. Involvement of the polycystin pathway in intra-
cellular vesicle transport would be consistent with the
inferred functions of polycystin-related molecules in the
acrosome reaction, male mating in C. elegans and the
human disorder mucolipidosis type IV, as well as with
direct observations [29]. The ability to formulate testable
hypothesis at the level of discrete cellular pathways clearly
demonstrates the substantial progress the field has made
since discordant nucleotide sequences were discovered in
novel genes of patients with ADPKD. Questions that were
posed initially with the aim of furthering out understand-
ing of disease biology should yield answers about normal
biology, and the latter, in turn, should yield therapeutic
strategies for the disease. Therein will lie one of the many
successes of the genome project.
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